GFPC
ARKG icon

Global Financial Private Client’s ARK Genomic Revolution ETF ARKG Stock Holding History

Global Financial Private Client’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-44
Closed -$1.25K – 687
2024
Q1 		$1.25K Hold
44
– – ﹤0.01% 624
2023
Q4 		$1.44K Buy
+44
New +$1.2K ﹤0.01% 605
2023
Q2 		– Sell
-47
Closed -$1.4K – 673
2023
Q1 		$1.4K Hold
47
– – ﹤0.01% 601
2022
Q4 		$1.33K Sell
47
-112
-70% -$3.56K ﹤0.01% 593
2022
Q3 		$5.28K Sell
159
-21
-12% -$771 ﹤0.01% 465
2022
Q2 		$5.9K Hold
180
– – ﹤0.01% 448
2022
Q1 		$8.64K Sell
180
-9,383
-98% -$447K ﹤0.01% 423
2021
Q4 		$586K Buy
9,563
+1,018
+12% +$70.4K 0.28% 83
2021
Q3 		$640K Buy
8,545
+1,279
+18% +$107K 0.33% 77
2021
Q2 		$675K Buy
7,266
+3,375
+87% +$287K 0.38% 68
2021
Q1 		$348K Sell
3,891
-14
-0.4% -$1.39K 0.25% 85
2020
Q4 		$364K Buy
3,905
+463
+13% +$36.9K 0.29% 73
2020
Q3 		$223K Sell
3,442
-413
-11% -$24.2K 0.19% 87
2020
Q2 		$205K Buy
3,855
+588
+18% +$25.2K 0.18% 103
2020
Q1 		$95.2K Buy
3,267
+170
+5% +$5.68K 0.1% 145
2019
Q4 		$104K Buy
+3,097
New +$98.4K 0.09% 161

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Global Financial Private Client's ARKG Position: Q2 2024 in Review

Global Financial Private Client sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 44 shares — an estimated $1.25K sold.

Global Financial Private Client first reported a position in ARKG in Q4 2019 and held it in 16 quarters. The position peaked at $675K in Q2 2021. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Global Financial Private Client reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Global Financial Private Client sold 44 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $1.25K.
  • Global Financial Private Client first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 16 quarters.
  • Global Financial Private Client's ARK Genomic Revolution ETF position peaked at $675K in Q2 2021.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Global Financial Private Client's 13F filing for Q2 2024, filed 29 Jul 2024.